Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis
- PMID: 34581939
- DOI: 10.1007/s11655-021-3293-x
Active Components Formulation Developed from Fuzheng Huayu Recipe for Anti-Liver Fibrosis
Abstract
Objective: To screen the active components from Fuzheng Huayu Recipe (FZHY) and redesign a new recipe composed of the active components, and validate the effect of active components formulation from FZHY against liver fibrosis.
Methods: Thirty-two components from FZHY were evaluated for their activities against liver fibrosis respectively, with 6 kinds of cell models in vitro, including oxidative stressed hepatocyte in L-02, hypoxia injured/proliferative hepatic sinusoidal endothelial cells in SK-HEP-1 and human hepatic sinusoidal endothelial cells (HHSEC), and activated hepatic stellate cell in LX-2. The comprehensive activity of each component against liver fibrosis was scored according to the role of original herbs in FZHY and cell functions in fibrogenesis. Totally 7 active components were selected and combined with equal proportion to form a novel active components formulation (ACF). The efficacy of ACF on liver fibrosis were evaluated on activation of LX-2 and proliferation of HHSEC in vitro and in liver fibrosis model mice induced by dimethylnitrosamine (DMN). Totally 72 mice were divided into 6 groups using a random number table, including normal, high-dose ACF control (20 µ mol/L × 7 components/kg body weight), model, low-, medium-, high-dose ACF groups (5, 10, 20 µ mol/L × 7 components/kg body weight, respectively). Hematoxylin eosin and Sirius red stainings were used to observe inflammation and fibrosis change of liver tissue; scanning electron microscopy (SEM) and transmission electron microscopy (TEM) were utilized to observe the effect of ACF on ultrastructure of hepatic sinusoids.
Results: Fifteen components from FZHY showed higher scores for their activity on against liver fibrosis. Among them, 7 components including tanshinone II A, salvianolic acid B, cordycepin, amygdalin, quercetin, protopanaxatriol, and schizandrin B were recombined with equal proportions to form ACF. ACF at 1,2, 4 µ mol/L showed strong inhibitory effects on activation of LX-2 and proliferation of HHSEC in vitro (all P<0.01). Compared with the model group, ACF attenuated liver collagen deposition, improved sinusoidal capillarization in a dose-dependent manner (all P<0.05).
Conclusion: ACF exerts a satisfactory effect against experimental liver fibrosis and attenuates sinusoidal capillarization, which warrant a further research and development for herbal components formulation on liver fibrosis.
Keywords: Chinese medicine; Fuzheng Huayu Recipe; active components formulation; hepatic sinusoidal capillarization; hepatic stellate cells; liver fibrosis.
© 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Investigation of the absorbed and metabolized components of Danshen from Fuzheng Huayu recipe and study on the anti-hepatic fibrosis effects of these components.J Ethnopharmacol. 2013 Jul 9;148(2):691-700. doi: 10.1016/j.jep.2013.05.031. Epub 2013 May 22. J Ethnopharmacol. 2013. PMID: 23707207
-
Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.BMC Complement Altern Med. 2014 Nov 18;14:449. doi: 10.1186/1472-6882-14-449. BMC Complement Altern Med. 2014. PMID: 25407538 Free PMC article.
-
[Effect of fuzheng huayu recipe and huangqi tang on DMN-induced experimental liver cirrhosis in rats].Zhongguo Zhong Yao Za Zhi. 2010 Jul;35(13):1740-4. doi: 10.4268/cjcmm20101319. Zhongguo Zhong Yao Za Zhi. 2010. PMID: 20862970 Chinese.
-
Progress in clinical and basic research of fuzheng Huayu formula for the treatment of liver fibrosis.J Ethnopharmacol. 2024 Jun 12;327:118018. doi: 10.1016/j.jep.2024.118018. Epub 2024 Mar 5. J Ethnopharmacol. 2024. PMID: 38453100 Review.
-
Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula.J Ethnopharmacol. 2020 Apr 6;251:112442. doi: 10.1016/j.jep.2019.112442. Epub 2019 Dec 28. J Ethnopharmacol. 2020. PMID: 31891799 Review.
Cited by
-
A detailed overview of quercetin: implications for cell death and liver fibrosis mechanisms.Front Pharmacol. 2024 May 23;15:1389179. doi: 10.3389/fphar.2024.1389179. eCollection 2024. Front Pharmacol. 2024. PMID: 38855739 Free PMC article. Review.
-
Chinese guidelines on the management of ascites in cirrhosis : Chinese Society of Hepatology, Chinese Medical Association.Hepatol Int. 2024 Aug;18(4):1071-1089. doi: 10.1007/s12072-024-10697-z. Epub 2024 Jul 9. Hepatol Int. 2024. PMID: 38980598
-
Tanshinone IIA regulates the TGF-β1/Smad signaling pathway to ameliorate non-alcoholic steatohepatitis-related fibrosis.Exp Ther Med. 2022 Jun 1;24(1):486. doi: 10.3892/etm.2022.11413. eCollection 2022 Jul. Exp Ther Med. 2022. PMID: 35761808 Free PMC article.
-
Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug.Front Oncol. 2023 Jan 31;13:1071415. doi: 10.3389/fonc.2023.1071415. eCollection 2023. Front Oncol. 2023. PMID: 36798821 Free PMC article. Review.
-
Formulation and Evaluation on Synergetic Anti-Hepatoma Effect of a Chemically Stable and Release-Controlled Nanoself-Assembly with Natural Monomers.Int J Nanomedicine. 2023 Jun 22;18:3407-3428. doi: 10.2147/IJN.S408416. eCollection 2023. Int J Nanomedicine. 2023. PMID: 37377983 Free PMC article.
References
-
- Mercedes F, David S, Jordi B, Isabelle C, Massimo P, Jaume B. Angiogenesis in liver disease. J Hepatol 2009;50:604–620. - DOI
-
- DeLeve LD. Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology 2015;61:1740–1746. - DOI
-
- Thabut D, Shah V. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?. J Hepatol 2010;53:976–980. - DOI
-
- Friedman Scott L. Hepatic fibrosis: emerging therapies. Dig Dis 2015;33:504–507. - DOI
-
- Lee Youngmin A, Wallace Michael C, Friedman Scott L. Pathobiology of liver fibrosis: a translational success story. Gut 2015;64:830–841. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
